TenX Keane Acquisition

YTD

ALL

Why Robinhood?

You can watch TENK and buy or sell other stocks, ETFs, and their options commission-free!

About TENK

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.

CEO

Leonard L. Mazur, MBA

CEOLeonard L. Mazur, MBA

Employees

—

Employees—

Headquarters

Cranford, New Jersey

HeadquartersCranford, New Jersey

Founded

Employees

—

Employees—

TENK Key Statistics

Market cap

65.56M

Market cap65.56M

Price-Earnings ratio

-4.81

Price-Earnings ratio-4.81

Dividend yield

—

Dividend yield—

Average volume

69.37K

Average volume69.37K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$49.00

52 Week high$49.00

52 Week low

$0.5506

52 Week low$0.5506

People also own

Based on the portfolios of people who own TENK. This list is generated using Robinhood data, and it’s not a recommendation.

AMTD Digital Inc. America…